Thromboprophylaxis practice patterns in hip fracture surgery patients: Experience in Perth, Western Australia

ANZ Journal of Surgery

Volumn 73, Issue 10, 2003, Pages 826-829

  Wan, Susan ^a   Ting, Jeannette ^a   Olsen, Amanda ^a   Croser, John ^b   Eikelboom, John W ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Aspirin; Hip fractures; Low molecular weight heparin; Thromboembolism; Venous thrombosis; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AGED; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE DURATION; EXPERIENCE; FEMALE; HIP FRACTURE; HIP SURGERY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; SURGICAL PATIENT; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT OUTCOME; FEMUR NECK FRACTURE; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; THROMBOEMBOLISM; VEIN THROMBOSIS;

AGED; ANTICOAGULANTS; FEMALE; FEMORAL NECK FRACTURES; GUIDELINE ADHERENCE; HIP FRACTURES; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 1542706468     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2003.02781.x     Document Type: Article

References (25)

1. Silverstein MD, Heit JA, Mohr DN, Patterson TM, O'Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch. Intern. Med. 1998; 158: 585-93.
2. Nordstrom M, Lindblad B. Autopsy-verified venous thromboembolism within a defined urban population: the city of Malmo, Sweden. APMIS 1998; 106: 378-84.
3. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J. R. Soc. Med. 1989; 82: 203-5.
4. Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest 2001; 119: 132S-75S.
5. Nicolaides AN, Breddin HK, Fareed J et al. Prevention of venous thromboembolism: International Consensus Statement: Guidelines compiled in accordance with the scientific evidence. Int. Angiol. 2001; 20: 1-37.
6. Van Balen R, Steyerberg EW, Polder JJ, Ribbers TLM, Habbema JDF, Cools HJM. Hip fracture in elderly patients: outcomes for function, quality of life and type of residence. Clin. Orthop. 2001; 390: 232-43.
7. Lyons A. Clinical outcomes and treatment of hip fracture. Am. J. Med. 1997; 103: 51S-63S.
8. Sanders KM, Seeman E, Ugoni AM et al. Age- and gender-specific rate of fractures in Australia: a population-based study. Osteoporos. Int. 1999; 10: 240-7.
9. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopaedic and urologic surgery. N. Engl. J. Med. 1988; 318: 1162-73.
10. Handoll HH, Farrar MJ, McBirnie J et al. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst. Rev. 2002; 4: CD000305.
11. Amarigiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2000; 3: CD001484.
12. Pulmonary Embolism Prevention Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention Trial. Lancet 2000; 355: 1295-302.
13. Stratton MA, Anderson FA, Bussey HI et al. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch. Intern. Med. 2000; 160: 334-40.
14. Todd CJ, Freeman CJ, Camilleri-Ferrante C et al. Differences in mortality after fracture of hip: the East Anglican audit. BMJ 1995; 310: 904-8.
15. Fletcher JP, Koutts J, Ockelford PA. Deep vein thrombosis prophylaxis: a survey of current practice in Australia and New Zealand. Aust. N.Z. J. Surg. 1992; 62: 601-5.
16. Rodgers A, Gray H, MacMahon S. Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons. Aust. N.Z. J. Surg. 1994; 64: 167-72.
17. Walker N, Rodgers A, Gray H. Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand. ANZ J. Surg. 2002; 72: 335-8.
18. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358: 9-15.
19. Douketis JD, Eikelboom JW, Quinlan DJ, Willan AR, Crowther MA. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch. Intern. Med. 2002; 162: 1465-71.
20. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis and death following primary hip or knee arthroplasty. Anesthesiology 2002; 96: 1140-6.
21. Perez JV, Warwick DJ, Case CP, Bannister GC. Death after proximal femoral fracture: an autopsy study. Injury 1995; 26: 237-40.
22. Ahmad HA, Geissler A, MacLellan DG. Deep venous thrombosis prophylaxis: are guidelines being followed? ANZ J. Surg. 2002; 72: 331-4.
23. Fletcher JP. Venous thromboembolism practice: applying evidence-based guidelines. ANZ J. Surg. 2003; 72: 320.
24. Anderson FA, Wheeler HB, Goldberg BJ et al. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for VTE. Ann. Intern. Med. 1994; 154: 669-77.
25. Balas EA, Weingarten LS, Gard CT et al. Improving preventive care by prompting physicians. Arch. Intern. Med. 2000; 160: 301-8.